Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef

Eduardo O'Neill, Lillian S. Kuo, John F. Krisko, Diana R. Tomchick, J. Victor Garcia, John L. Foster

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

The human immunodeficiency virus type 1 (HIV-1) early gene product Nef is a multifunctional protein that alters numerous pathways of T-cell function, including endocytosis, signal transduction, vesicular trafficking, and immune modulation, and is a major determinant of pathogenesis. Individual Nef functions include PAK-2 activation, CD4 downregulation, major histocompatibility complex (MHC) class I downregulation, and enhancement of viral particle infectivity. How Nef accomplishes its multiple tasks presents a difficult problem of mechanistic analysis because of the complications associated with multiple, overlapping functional domains in the context of significant sequence variability. To address these issues we determined the conservation of each Nef residue based on 1,643 subtype B Nef sequences. Mutational analysis based on conservative substitutions and Nef sequence data allowed us to search for amino acids on the surface of Nef that are specifically required for PAK-2 activation. We found residues 85, 89, and 191 to be highly significant determinants for Nefs PAK-2 activation function but functionally unlinked to CD4 and MHC class I downregulation or enhancement of infectivity. These residues are not conserved across HIV-1 subtypes but are confined to separate sets of surface elements within a subtype. Thus, L85/H89/F191 and F85/F89/R191 are dominant in subtype B and subtype E or C, respectively. Our results provide support for developing subtype-specific interventions in HIV-1 disease.

Original languageEnglish (US)
Pages (from-to)1311-1320
Number of pages10
JournalJournal of Virology
Volume80
Issue number3
DOIs
StatePublished - Feb 2006

Fingerprint

Human immunodeficiency virus 1
HIV-1
Down-Regulation
major histocompatibility complex
Major Histocompatibility Complex
pathogenicity
nef Gene Products
endocytosis
Virus Diseases
Endocytosis
virion
Virion
signal transduction
Signal Transduction
pathogenesis
T-lymphocytes
T-Lymphocytes
Amino Acids
amino acids
Proteins

ASJC Scopus subject areas

  • Immunology

Cite this

Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef. / O'Neill, Eduardo; Kuo, Lillian S.; Krisko, John F.; Tomchick, Diana R.; Garcia, J. Victor; Foster, John L.

In: Journal of Virology, Vol. 80, No. 3, 02.2006, p. 1311-1320.

Research output: Contribution to journalArticle

O'Neill, Eduardo ; Kuo, Lillian S. ; Krisko, John F. ; Tomchick, Diana R. ; Garcia, J. Victor ; Foster, John L. / Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef. In: Journal of Virology. 2006 ; Vol. 80, No. 3. pp. 1311-1320.
@article{e6f7d2f8e74c482194a216e1b4c700f8,
title = "Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef",
abstract = "The human immunodeficiency virus type 1 (HIV-1) early gene product Nef is a multifunctional protein that alters numerous pathways of T-cell function, including endocytosis, signal transduction, vesicular trafficking, and immune modulation, and is a major determinant of pathogenesis. Individual Nef functions include PAK-2 activation, CD4 downregulation, major histocompatibility complex (MHC) class I downregulation, and enhancement of viral particle infectivity. How Nef accomplishes its multiple tasks presents a difficult problem of mechanistic analysis because of the complications associated with multiple, overlapping functional domains in the context of significant sequence variability. To address these issues we determined the conservation of each Nef residue based on 1,643 subtype B Nef sequences. Mutational analysis based on conservative substitutions and Nef sequence data allowed us to search for amino acids on the surface of Nef that are specifically required for PAK-2 activation. We found residues 85, 89, and 191 to be highly significant determinants for Nefs PAK-2 activation function but functionally unlinked to CD4 and MHC class I downregulation or enhancement of infectivity. These residues are not conserved across HIV-1 subtypes but are confined to separate sets of surface elements within a subtype. Thus, L85/H89/F191 and F85/F89/R191 are dominant in subtype B and subtype E or C, respectively. Our results provide support for developing subtype-specific interventions in HIV-1 disease.",
author = "Eduardo O'Neill and Kuo, {Lillian S.} and Krisko, {John F.} and Tomchick, {Diana R.} and Garcia, {J. Victor} and Foster, {John L.}",
year = "2006",
month = "2",
doi = "10.1128/JVI.80.3.1311-1320.2006",
language = "English (US)",
volume = "80",
pages = "1311--1320",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "3",

}

TY - JOUR

T1 - Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef

AU - O'Neill, Eduardo

AU - Kuo, Lillian S.

AU - Krisko, John F.

AU - Tomchick, Diana R.

AU - Garcia, J. Victor

AU - Foster, John L.

PY - 2006/2

Y1 - 2006/2

N2 - The human immunodeficiency virus type 1 (HIV-1) early gene product Nef is a multifunctional protein that alters numerous pathways of T-cell function, including endocytosis, signal transduction, vesicular trafficking, and immune modulation, and is a major determinant of pathogenesis. Individual Nef functions include PAK-2 activation, CD4 downregulation, major histocompatibility complex (MHC) class I downregulation, and enhancement of viral particle infectivity. How Nef accomplishes its multiple tasks presents a difficult problem of mechanistic analysis because of the complications associated with multiple, overlapping functional domains in the context of significant sequence variability. To address these issues we determined the conservation of each Nef residue based on 1,643 subtype B Nef sequences. Mutational analysis based on conservative substitutions and Nef sequence data allowed us to search for amino acids on the surface of Nef that are specifically required for PAK-2 activation. We found residues 85, 89, and 191 to be highly significant determinants for Nefs PAK-2 activation function but functionally unlinked to CD4 and MHC class I downregulation or enhancement of infectivity. These residues are not conserved across HIV-1 subtypes but are confined to separate sets of surface elements within a subtype. Thus, L85/H89/F191 and F85/F89/R191 are dominant in subtype B and subtype E or C, respectively. Our results provide support for developing subtype-specific interventions in HIV-1 disease.

AB - The human immunodeficiency virus type 1 (HIV-1) early gene product Nef is a multifunctional protein that alters numerous pathways of T-cell function, including endocytosis, signal transduction, vesicular trafficking, and immune modulation, and is a major determinant of pathogenesis. Individual Nef functions include PAK-2 activation, CD4 downregulation, major histocompatibility complex (MHC) class I downregulation, and enhancement of viral particle infectivity. How Nef accomplishes its multiple tasks presents a difficult problem of mechanistic analysis because of the complications associated with multiple, overlapping functional domains in the context of significant sequence variability. To address these issues we determined the conservation of each Nef residue based on 1,643 subtype B Nef sequences. Mutational analysis based on conservative substitutions and Nef sequence data allowed us to search for amino acids on the surface of Nef that are specifically required for PAK-2 activation. We found residues 85, 89, and 191 to be highly significant determinants for Nefs PAK-2 activation function but functionally unlinked to CD4 and MHC class I downregulation or enhancement of infectivity. These residues are not conserved across HIV-1 subtypes but are confined to separate sets of surface elements within a subtype. Thus, L85/H89/F191 and F85/F89/R191 are dominant in subtype B and subtype E or C, respectively. Our results provide support for developing subtype-specific interventions in HIV-1 disease.

UR - http://www.scopus.com/inward/record.url?scp=31144476786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31144476786&partnerID=8YFLogxK

U2 - 10.1128/JVI.80.3.1311-1320.2006

DO - 10.1128/JVI.80.3.1311-1320.2006

M3 - Article

C2 - 16415008

AN - SCOPUS:31144476786

VL - 80

SP - 1311

EP - 1320

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 3

ER -